Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FX32L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,739
Award facts
- Contract value 100% obligated
- $9,739.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,739.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL units. This non-competitive delivery order is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order supports the company's role as a critical pharmaceutical distributor for military and federal healthcare systems, providing access to brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
The award reflects AmerisourceBergen's established position as a prime vendor in the DLA's pharmaceutical supply chain, serving defense healthcare customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, the company has demonstrated capability to fulfill federal medical procurement requirements through its extensive portfolio of competitively awarded contracts. The delivery order is scheduled for ultimate completion on August 19, 2025, with pricing established on a firm fixed-price basis typical of routine pharmaceutical supply transactions within the broader pharmaceutical prime vendor program supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FX32L?
SPE2DB25FX32L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FX32L worth?
The government has obligated $9,739 on SPE2DB25FX32L.
Is contract SPE2DB25FX32L an order under another contract?
Yes. SPE2DB25FX32L is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX32L competed?
The extent of competition for SPE2DB25FX32L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award